Optimization of eGFP expression using a modified baculovirus expression system

Journal of Biotechnology

Volumn 173, Issue 1, 2014, Pages 41-46

  Ge, Jingping ^a   Jin, Liying ^a   Tang, Xiaoyan ^a   Gao, Dongni ^a   An, Qi ^a   Ping, Wenxiang ^a  

^a HEILONGJIANG UNIVERSITY   (China)

Author keywords

ITRs; Recombinant baculovirus; VSV GED; WPRE; WSSV ie1 promoter

Indexed keywords

ITRS; RECOMBINANT BACULOVIRUS; VSV-GED; WPRE; WSSV IE1 PROMOTER;

CELL CULTURE; GENE EXPRESSION; PROTEINS; VIRUSES;

EFFICIENCY;

ENHANCED GREEN FLUORESCENT PROTEIN; GUANINE NUCLEOTIDE BINDING PROTEIN; VIRUS PROTEIN;

ARTICLE; BACULOVIRUS EXPRESSION SYSTEM; CONTROLLED STUDY; CYTOMEGALOVIRUS; GENE CASSETTE; GENETIC TRANSDUCTION; INVERTED TERMINAL REPEAT; NONHUMAN; PRIORITY JOURNAL; PROCESS OPTIMIZATION; PROTEIN EXPRESSION; REPORTER GENE; VESICULAR STOMATITIS VIRUS; WHITE SPOT SYNDROME VIRUS; WOODCHUCK HEPATITIS VIRUS;

ITRS; RECOMBINANT BACULOVIRUS; VSV-GED; WPRE; WSSV IE1 PROMOTER;

ANIMALS; BACULOVIRIDAE; CELL LINE; CHICK EMBRYO; CHO CELLS; CRICETULUS; DEPENDOVIRUS; DNA, VIRAL; GENES, REPORTER; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HEPATITIS B VIRUS, WOODCHUCK; MEMBRANE GLYCOPROTEINS; PROMOTER REGIONS, GENETIC; RESPONSE ELEMENTS; SF9 CELLS; SPODOPTERA; TERMINAL REPEAT SEQUENCES; TRANSDUCTION, GENETIC; VESICULAR STOMATITIS INDIANA VIRUS; VIRAL ENVELOPE PROTEINS;

EID: 84893359490     PISSN: 01681656     EISSN: 18734863     Source Type: Journal    
DOI: 10.1016/j.jbiotec.2014.01.003     Document Type: Article

References (35)

1. Airenne K.J., Hiltunen M.O., Turunen M.P., Turunen A.M., Laitinen O.H., Kulomaa M.S., Ylä-Herttuala S. Baculovirus-mediated periadventitial gene transfer to rabbit carotid artery. Gene Therapy 2000, 17:1499-1504.
2. Barsoum J., Brown R., McKee M., Boyce F.M. Efficient transduction of mammalian cells by a recombinant baculovirus having the vesicular stomatitis virus G glycoprotein. Human Gene Therapy 1997, 8:2011-2018.
3. Cheng T., Xu C.Y., Wang Y.B., Chen M., Wu T., Zhang J., Xia N.S. A rapid and efficient method to express target genes in mammalian cells by baculovirus. World Journal of Gastroenterology 2004, 10:1612-1618.
4. Condreay J.P., Witherspoon S.M., Clay W.C., Kost T.A. Transient and stable gene expression in mammalian cells transduced with a recombinant baculovirus vector. Proceedings of the National Academy of Sciences 1999, 96:127-132.
5. Donello J.E., Loeb J.E., Hope T.J. Woodchuck hepatitis virus contains a tri-partite posttranscriptional regulatory element. Journal of Virology 1998, 72:5085-5092.
6. Fitzsimons H.L., Bland R.J., During M.J. Promoters and regulatory elements that improve adeno-associated virus transgene expression in the brain. Methods 2002, 28:227-236.
7. Flotte T.R., Afione S.A., Solow R., Drumm M.L., Markakis D., Guggino W.B., Zeitlin P.L., Carter B.J. Expression of the cystic fibrosis transmembrane conductance regulator from a novel adeno-associated virus promoter. Journal of Biological Chemistry 1993, 268:3781-3790.
8. Fu Y., Wang Y., Evans S.M. Viral sequences enable efficient and tissue-specific expression of transgenes in Xenopus. Nature Biotechnology 1998, 16:253-257.
9. Ghosh S., Parvez M.K., Banergee K., Sarin S.K., Hasnain S.E. Baculovirus as mammalian cell expression vector for gene therapy: an emerging strategy. Molecular Therapy 2002, 6:5-11.
10. He F., Ho Y., Yu L., Kwang J. WSSV ie1 promoter is more efficient than CMV promoter to express H5 hemagglutinin from influenza virus in baculovirus as a chicken vaccine. BioMed Central Microbiology 2008, 8:1-10.
11. Hsiao C.D., Hsish F.J., Tsai H.J. Enhanced expression and stable transmission of transgenes flanked by inverted terminal repeats from adeno-associated virus in zebrafish. Developmental Dynamics 2001, 220:323-336.
12. Hunt L., Batard P., Jordan M., Wurm F.M. Fluorescent proteins in animal cells for process development: optimization of sodium butyrate treatment as an example. Biotechnology and Bioengineering 2002, 77:528-537.
13. Johnston K.M., Jacoby D., Pechan P.A., Fraefel C., Borghesani P., Schuback D., Dunn R.J., Smith F.I., Breakefield X.O. HSV/AAV hybrid amplicon vectors extend transgene expression in human glioma cells. Human Gene Therapy 1997, 8:359-370.
14. Kaikkonen M.U., Raty J.K., Airenne K.J., Wirth T., Heikura T., Yla-Herttuala S. Truncated vesicular stomatitis virus G protein improves baculovirus transduction efficiency in vitro and in vivo. Gene Therapy 2006, 13:304-312.
15. Kost T.A., Condreay J.P. Recombinant baculoviruses as mammalian cell gene-delivery vectors. Trends in Biotechnology 2002, 20:173-180.
16. Lam P., Hui K.M., Wang Y., Allen P.D., Louis D.N., Yuan C.J., Breakefield X.O. Dynamics of transgene expression in human glioblastoma cells mediated by herpes simplex virus/adeno-associated virus amplicon vectors. Human Gene Therapy 2002, 13:2147-2159.
17. Li Y., Wang X., Guo H., Wang S. Axonal transport of recombinant baculovirus vectors. Molecular Therapy 2004, 10:1121-1129.
18. Mähönen A.J., Airenne K.J., Purola S., Peltomaa E., Kaikkonen M.U., Riekkinen M.S., Heikura T., Kinnunen K., Roschier M.M., Wirth T., Yl̈a-Herttuala S. Post-transcriptional regulatory element boosts baculovirus-mediated gene expression in vertebrate cells. Journal of Biotechnology 2007, 131:1-8.
19. Makela A.R., Matilainen H., White D.J., Ruoslahti E., Oker-Blom C. Enhanced baculovirus-mediated transduction of human cancer cells by tumor-homing peptides. Journal of Virology 2006, 80:6603-6611.
20. Matilainen H., Makela A.R., Riikonen R., Saloniemi T., Korhonen E., Hyypia T., Heino J., Grabherr R., Oker-Blom C. RGD motifs on the surface of baculovirus enhance transduction of human lung carcinoma cells. Journal of Biotechnology 2006, 125:114-126.
21. Palmer T.D., Thompson A.R., Miller A.D. Production of human factor IX in animals by genetically modified skin fibroblasts: potential therapy for hemophilia B. Blood 1989, 73:438-445.
22. Park S.W., Lee H.K., Kim T.G., Yoon S.K., Paik S.Y. Hepatocyte-specific gene expression by baculovirus pseudotyped with vesicular stomatitis virus envelope glycoprotein. Biochemical and Biophysical Research Communications 2001, 289:444-450.
23. Peel A.L., Klein R.L. Adeno-associated virus vectors: activity and applications in the CNS. Journal of Neuroscience Methods 2000, 98:95-104.
24. Philip R., Brunette E., Kilinski L., Murugesh D., McNally M.A., Ucar K., Rosen-blatt J., Okarma T.B., Lebkowski J.S. Efficient and sustained gene expression in primary T lymphocytes and primary and cultured tumor cells mediated by adeno-associated virus plasmid DNA complexed to cationic liposomes. Molecular and Cellular Biology 1994, 14:2411-2418.
25. Pieroni L., Maione D., La Monica N. In vivo gene transfer in mouse skeletal muscle mediated by baculovirus vectors. Human Gene Therapy 2001, 12:871-881.
26. Raty J.K., Airenne K.J., Marttila A.T., Marjomaki V., Hytonen V.P., Lehto-lainen P., Laitinen O.H., Mähönen A.J., Kulomaa M.S., Yla-Herttuala S. Enhanced gene delivery by avidin-displaying baculovirus. Molecular Therapy 2004, 9:282-291.
27. Salminen M., Airenne K.J., Rinnankoski R., Reimari J., Välilehto O., Rinne J., Suikkanen S., Kukkonen S., Ylä-Herttuala S., Kulomaa M.S., Ranta M.V. Improvement in nuclear entry and transgene expression of baculoviruses by disintegration of microtubules in human hepatocytes. Journal of Virology 2005, 795(27):0-2728.
28. Shoji I., Aizaki H., Tani H., Ishii K., Chiba T., Saito I., Miyamura T., Matsuura Y. Efficient gene transfer into various mammalian cells, including non-hepatic cells by baculovirus vectors. Journal of General Virology 1997, 78:2657-2664.
29. Spector D.L., Goldman R.D., Leinwand L.A. Cells 1988, Cold Spring Harbor Laboratory Press, New York.
30. Tani H., Limn C.K., Yap C.C., Onishi M., Nozaki M., Nishimune Y., Okahashi N., Kitagawa Y., Watanabe R., Mochizuki R., Moriishi K., Matsuura Y. In vitro and in vivo gene delivery by recombinant baculoviruses. Journal of Virology 2003, 77:9799-9808.
31. Tani H., Nishijima M., Ushijima H., Miyamura T., Matsuura Y. Characterization of cell surface determinants important for baculovirus infection. Journal of Virology 2001, 279:343-353.
32. van Loo N.D., Fortunati E., Ehlert E., Rabelink M., Grosveld F., Scholte B.J. Baculovirus infection of nondividing mammalian cells: mechanisms of entry and nuclear transport of capsids. Journal of Virology 2001, 75:961-970.
33. Vieweg J., Boczkowski D., Roberson K.M., Roberson K.M., Edwards D.W., Philip M., Philip R., Rudoll T., Smith C., Robertson C., Gilboa E. Efficient gene transfer with adeno-associated virus-based plasmids complexed to cationic liposomes for gene therapy of human prostate cancer. Cancer Research 1995, 55:2366-2372.
34. Wang C.Y., Wang S. Adeno-associated virus inverted terminal repeats improve neuronal transgene expression mediated by baculovirus vectors in rat brain. Human Gene Therapy 2005, 16:1219-1226.
35. Xu R., Janson C.G., Mastakov M., Lawlor P., Young D., Mouravlev A., Fitzsimons H., Choi K.L., Ma H., Dragunow M., Leone P., Chen Q., Dicker B., During M.J. Quantitative comparison of expression with adeno-associated virus (AAV-2) brain-specific gene cassettes. Gene Therapy 2001, 8:1323-1332.